Class 3 MAPK Mutation in Langerhans cell histiocytosis and Trametinib—Reporting Two Contrarian Responses

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-07-20
DOI
https://doi.org/10.1002/pbc.31928
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Class 3 MAPK Mutation in Langerhans cell histiocytosis and Trametinib—Reporting Two Contrarian Responses

Natalia Wojciechowska, Anish Ray, Jason Wang, Alejandra Cervantes‐Dominguez
Pediatric Blood & Cancer
Histiocytic Disorders and Treatments
article

Class 3 MAPK Mutation in Langerhans cell histiocytosis and Trametinib—Reporting Two Contrarian Responses

Natalia Wojciechowska, Anish Ray, Jason Wang, Alejandra Cervantes‐Dominguez
article en

Abstract

No abstract available for this paper.
Pediatric Blood & CancerVol. 72(10)
Texas Christian University (US), Cook Children's Medical Center (US)
Openalex Percentile: Top 77%
Histiocytic Disorders and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Class 3 MAPK Mutation in Langerhans cell histiocytosis and Trametinib—Reporting Two Contrarian Responses — Natalia Wojciechowska, Anish Ray, et al. · Pediatric Blood & Cancer (2025) | TGRS Research Map | TGRS